Efficacy of Quinoxaline-2-Carboxylate 1,4-Di- N -Oxide Derivatives in Experimental Tuberculosis

MLA

Scott G. Franzblau, et al. “Efficacy of Quinoxaline-2-Carboxylate 1,4-Di- N -Oxide Derivatives in Experimental Tuberculosis.” Antimicrobial Agents and Chemotherapy, vol. 52, Sept. 2008, pp. 3321–26. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c43d676f4812f7e35f046752469c8d73&authtype=sso&custid=ns315887.

APA

Scott G. Franzblau, Beatriz Solano, Silvia Pérez-Silanes, Anne J. Lenaerts, Raquel Villar, Robert C. Goldman, Antonio Monge, Asunción Burguete, Esther Vicente, Ignacio Aldana, Sang-Hyun Cho, & Joseph A. Maddry. (2008). Efficacy of Quinoxaline-2-Carboxylate 1,4-Di- N -Oxide Derivatives in Experimental Tuberculosis. Antimicrobial Agents and Chemotherapy, 52, 3321–3326.

Chicago

Scott G. Franzblau, Beatriz Solano, Silvia Pérez-Silanes, Anne J. Lenaerts, Raquel Villar, Robert C. Goldman, Antonio Monge, et al. 2008. “Efficacy of Quinoxaline-2-Carboxylate 1,4-Di- N -Oxide Derivatives in Experimental Tuberculosis.” Antimicrobial Agents and Chemotherapy 52 (September): 3321–26. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....c43d676f4812f7e35f046752469c8d73&authtype=sso&custid=ns315887.